Hepatic and gut clearance of catecholamines in the conscious dog

Metabolism: Clinical and Experimental

Volumn 48, Issue 2, 1999, Pages 259-263

  Chu, Chang An ^a   Sindelar, Dana K ^a   Neal, Doss W ^a   Cherrington, Alan D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE METABOLISM; DOG; GASTROINTESTINAL TRANSIT; HEPATIC VEIN; INTESTINE ABSORPTION; LIVER CLEARANCE; NONHUMAN; PLASMA CLEARANCE; PORTAL VEIN; PRIORITY JOURNAL; STRESS;

EID: 13044251832     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90044-6     Document Type: Article

References (25)

1. Silverberg AB, Shah SD, Haymond MW, et al: Norepinephrine: Hormone and neurotransmitter in man. Am J Physiol 234:E252-E256, 1978
2. Sacca L, Vigorito C, Cicala M, et al: Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in human. Am J Physiol 245:E294-E302, 1983
3. Keller U. Gerber PPG, Stauffacher W: Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans. Am J Physiol 247:E732-E739, 1984
4. Stevenson RW, Steiner KE, Connolly CC, et al: Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol 260:E363-E370, 1991
5. Connolly CC, Steiner KE, Stevenson RW, et al: Regulation of glucose metabolism by norepinephrine in conscious dogs. Am J Physiol 261:E764-E772, 1991
6. Connolly CC, Steiner KE. Stevenson RW, et al: Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs. Am J Physiol 261:E466-E472, 1991
7. Chu CA, Sindelar DK, Neal DN, et al: Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest 99:1044-1056, 1997
8. Chu CA, Sindelar DK. Neal DN, et al: Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis. Am J Physiol 271:E127-E136, 1996
9. Clutter WE, Rizza RA, Gerich JE, et al: Regulation of glucose metabolism by sympathochromaffin catecholamines. Diabetes Metab Rev 4:1-15, 1988
10. Christensen NJ, Galbo H, Gjerris A, et al: Whole body and regional clearances of norepinephrine and adrenaline in man. Acta Physiol Scand Suppl 527:17-20, 1984
11. Clutter WE, Bier DM, Shah SD, et al: Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66:94-101, 1980
12. Cryer PE, Rizza RA, Haymond MW, et al: Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alphaadrenergic, mechanism in man. Metabolism 29:1114-1118, 1980
13. Henriksen JH, Ring-Larsen H, Kanstrup IL: Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 25:1034-1043, 1984
14. Vollenweider L, Tappy L, Owlya R, et al: Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes 44:641-645, 1995
15. Muntzel MS, Morgan DA. Mark AL, et al: Intracerebroventricular insulin produces nonuniform regional increase in sympathetic nerve activity. Am J Physiol 267:R1350-R1355, 1994
16. Tack CJ, Lenders JW, Willemsen JJ, et al: Insulin stimulates epinephrine release under euglycemia conditions in humans. Metabolism 47:243-249, 1998
17. Rooney DR Edgar JD, Sheridan B, et al: The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest 21:430-435, 1991
18. Bunag RD, Krizsan-Agbas D. Itoh H: Sympathetic activation by chronic insulin treatment in conscious rats. J Pharmacol Exp Ther 259:131-138, 1998
19. Moghimzadeh E, Nobin A, Rosengren E: Fluorescence microscopical and chemical characterization of the adrenergic innervation in mammalian liver tissue. Cell Tissue Res 230:605-615, 1983
20. Brown MJ, Jenner DA, Allison DJ. et al: Variation in individual organ release of noradrenaline measured by an improved radioenzymatic technique: Limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci (Colch) 61:585-590, 1981
21. Jackman M, Wendling P, Friars D, et al: Metabolic, catecholamine, and endurance responses to caffeine during intense exercise. J Appl Physiol 81:1658-1663, 1996
22. Coker RH, Krishna MG, Zinker BA, et al: Sympathetic drive to liver and nonhepatic splanchnic tissue during prolonged exercise is increased in diabetes. Metabolism 46:1327-1332, 1997
23. Lefkowitz RJ, Hoffman BB, Taylor P: Neurotransmission: The autonomie and somatic motor nervous systems, in Hardman JG, Limbird LE (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics (ed 9). New York, NY, McGraw-Hill, 1996, pp 105-140
24. Haefely W, Hurlimann A, Thoenen H: Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve ending in the isolated perfused spleen of the cat. J Physiol 181:48-58, 1965
25. Yamaguchi N, Champlain D, Nadeau R: Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circ Res 36:662-668, 1975